EARN25

Biotech Stock Blasts Higher on Upbeat Trial Data

AVXL options are flying off the shelves this morning

Deputy Editor
Dec 2, 2022 at 10:46 AM
facebook X logo linkedin


Anavex Life Sciences Corp (NASDAQ:AVXL) is surging up 26.8% at $11.25 at last glance, and was earlier trading as high as $12.73. The biotech name released positive data from a mid-to-late stage trial evaluating its lead drug, ANAVEX 2-73, which is a potential treatment for early Alzheimer's disease. 

Options traders are blasting Anavex stock in response. So far, 15,000 calls and 21,000 puts have been exchanged -- 24 times the intraday average volume. The weekly 12/2 10-strike put is the most active contract, followed by the 9-strike call in the same weekly series, with new positions being opened at both. 

Today's pop has AVXL on track to recover this week's hefty losses, with the shares back above their 200-day moving average for the first time since Monday. The stock has been falling since its Mid-November peak, and is currently sporting a 33.7% year-to-date deficit. 

It's also worth noting that short interest represents a solid 13.5% of the stock's available float. It would take nearly 12 days to buy back these bearish bets, at AVXL's average pace of trading. 

 

 

 

You Don’t Need 25 Alerts -- You Need ONE You Can Trust!

That’s the idea behind Trade of the Week, Schaeffer’s newest trade alert.

Every Monday morning before the opening bell, you’ll receive a single, expertly researched trade recommendation -- built from the same proprietary research we’ve been using for over four decades.

It’s not just a signal.

It’s a plan designed for traders who are tired of jumping from alert to alert without ever finding their edge.

No juggling alerts. No switching directions mid-week. Just one clear, expertly researched trade idea -- delivered before the market even opens.

👉 JOIN RIGHT NOW FOR JUST $1 TO GET THE NEXT TRADE!